 | • レポートコード：MRC2-11QY08412 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、146ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は経口ワクチンのグローバル市場について調査・分析したレポートです。種類別（ロタウイルスワクチン、コレラワクチン、経口ポリオワクチン、その他）市場規模、用途別（公共、個人）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別経口ワクチンの競争状況、市場シェア ・世界の経口ワクチン市場：種類別市場規模 2015年-2020年（ロタウイルスワクチン、コレラワクチン、経口ポリオワクチン、その他） ・世界の経口ワクチン市場：種類別市場規模予測 2021年-2026年（ロタウイルスワクチン、コレラワクチン、経口ポリオワクチン、その他） ・世界の経口ワクチン市場：用途別市場規模 2015年-2020年（公共、個人） ・世界の経口ワクチン市場：用途別市場規模予測 2021年-2026年（公共、個人） ・北米の経口ワクチン市場分析：米国、カナダ ・ヨーロッパの経口ワクチン市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの経口ワクチン市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の経口ワクチン市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの経口ワクチン市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Merck、GSK、Sanofi、Lanzhou Institute、Serum Institute、Valneva、Shanghai United Cell、Bibcol、PaxVax、Vabiotech、Tiantan Biological、EuBiologics、Panacea Biotec Ltd、Bio-Med、Halfkin Bio-Pharmaceuticals ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.
Market Analysis and Insights: Global Oral Vaccine Market
The global Oral Vaccine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Oral Vaccine Scope and Market Size
Oral Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Oral Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Oral Vaccine market is segmented into
Rotavirus Vaccine
Cholera Vaccine
Oral Polio Vaccine
Others
Segment by Application, the Oral Vaccine market is segmented into
Public
Private
Regional and Country-level Analysis
The Oral Vaccine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Oral Vaccine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Oral Vaccine Market Share Analysis
Oral Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Oral Vaccine business, the date to enter into the Oral Vaccine market, Oral Vaccine product introduction, recent developments, etc.
The major vendors covered:
Merck
GSK
Sanofi
Lanzhou Institute
Serum Institute
Valneva
Shanghai United Cell
Bibcol
PaxVax
Vabiotech
Tiantan Biological
EuBiologics
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
1 Study Coverage
1.1 Oral Vaccine Product Introduction
1.2 Market Segments
1.3 Key Oral Vaccine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Oral Vaccine Market Size Growth Rate by Type
1.4.2 Rotavirus Vaccine
1.4.3 Cholera Vaccine
1.4.4 Oral Polio Vaccine
1.4.5 Others
1.5 Market by Application
1.5.1 Global Oral Vaccine Market Size Growth Rate by Application
1.5.2 Public
1.5.3 Private
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Oral Vaccine Market Size, Estimates and Forecasts
2.1.1 Global Oral Vaccine Revenue 2015-2026
2.1.2 Global Oral Vaccine Sales 2015-2026
2.2 Global Oral Vaccine, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Oral Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Oral Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Oral Vaccine Competitor Landscape by Players
3.1 Oral Vaccine Sales by Manufacturers
3.1.1 Oral Vaccine Sales by Manufacturers (2015-2020)
3.1.2 Oral Vaccine Sales Market Share by Manufacturers (2015-2020)
3.2 Oral Vaccine Revenue by Manufacturers
3.2.1 Oral Vaccine Revenue by Manufacturers (2015-2020)
3.2.2 Oral Vaccine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Oral Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Oral Vaccine Revenue in 2019
3.2.5 Global Oral Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Oral Vaccine Price by Manufacturers
3.4 Oral Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Oral Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Oral Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Oral Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Oral Vaccine Market Size by Type (2015-2020)
4.1.1 Global Oral Vaccine Sales by Type (2015-2020)
4.1.2 Global Oral Vaccine Revenue by Type (2015-2020)
4.1.3 Oral Vaccine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Oral Vaccine Market Size Forecast by Type (2021-2026)
4.2.1 Global Oral Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Oral Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Oral Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Oral Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Oral Vaccine Market Size by Application (2015-2020)
5.1.1 Global Oral Vaccine Sales by Application (2015-2020)
5.1.2 Global Oral Vaccine Revenue by Application (2015-2020)
5.1.3 Oral Vaccine Price by Application (2015-2020)
5.2 Oral Vaccine Market Size Forecast by Application (2021-2026)
5.2.1 Global Oral Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Oral Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Oral Vaccine Price Forecast by Application (2021-2026)
6 North America
6.1 North America Oral Vaccine by Country
6.1.1 North America Oral Vaccine Sales by Country
6.1.2 North America Oral Vaccine Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Oral Vaccine Market Facts & Figures by Type
6.3 North America Oral Vaccine Market Facts & Figures by Application
7 Europe
7.1 Europe Oral Vaccine by Country
7.1.1 Europe Oral Vaccine Sales by Country
7.1.2 Europe Oral Vaccine Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Oral Vaccine Market Facts & Figures by Type
7.3 Europe Oral Vaccine Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Oral Vaccine by Region
8.1.1 Asia Pacific Oral Vaccine Sales by Region
8.1.2 Asia Pacific Oral Vaccine Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Oral Vaccine Market Facts & Figures by Type
8.3 Asia Pacific Oral Vaccine Market Facts & Figures by Application
9 Latin America
9.1 Latin America Oral Vaccine by Country
9.1.1 Latin America Oral Vaccine Sales by Country
9.1.2 Latin America Oral Vaccine Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Oral Vaccine Market Facts & Figures by Type
9.3 Central & South America Oral Vaccine Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Oral Vaccine by Country
10.1.1 Middle East and Africa Oral Vaccine Sales by Country
10.1.2 Middle East and Africa Oral Vaccine Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Oral Vaccine Market Facts & Figures by Type
10.3 Middle East and Africa Oral Vaccine Market Facts & Figures by Application
11 Company Profiles
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Description and Business Overview
11.1.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Merck Oral Vaccine Products Offered
11.1.5 Merck Related Developments
11.2 GSK
11.2.1 GSK Corporation Information
11.2.2 GSK Description and Business Overview
11.2.3 GSK Sales, Revenue and Gross Margin (2015-2020)
11.2.4 GSK Oral Vaccine Products Offered
11.2.5 GSK Related Developments
11.3 Sanofi
11.3.1 Sanofi Corporation Information
11.3.2 Sanofi Description and Business Overview
11.3.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Sanofi Oral Vaccine Products Offered
11.3.5 Sanofi Related Developments
11.4 Lanzhou Institute
11.4.1 Lanzhou Institute Corporation Information
11.4.2 Lanzhou Institute Description and Business Overview
11.4.3 Lanzhou Institute Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Lanzhou Institute Oral Vaccine Products Offered
11.4.5 Lanzhou Institute Related Developments
11.5 Serum Institute
11.5.1 Serum Institute Corporation Information
11.5.2 Serum Institute Description and Business Overview
11.5.3 Serum Institute Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Serum Institute Oral Vaccine Products Offered
11.5.5 Serum Institute Related Developments
11.6 Valneva
11.6.1 Valneva Corporation Information
11.6.2 Valneva Description and Business Overview
11.6.3 Valneva Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Valneva Oral Vaccine Products Offered
11.6.5 Valneva Related Developments
11.7 Shanghai United Cell
11.7.1 Shanghai United Cell Corporation Information
11.7.2 Shanghai United Cell Description and Business Overview
11.7.3 Shanghai United Cell Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Shanghai United Cell Oral Vaccine Products Offered
11.7.5 Shanghai United Cell Related Developments
11.8 Bibcol
11.8.1 Bibcol Corporation Information
11.8.2 Bibcol Description and Business Overview
11.8.3 Bibcol Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Bibcol Oral Vaccine Products Offered
11.8.5 Bibcol Related Developments
11.9 PaxVax
11.9.1 PaxVax Corporation Information
11.9.2 PaxVax Description and Business Overview
11.9.3 PaxVax Sales, Revenue and Gross Margin (2015-2020)
11.9.4 PaxVax Oral Vaccine Products Offered
11.9.5 PaxVax Related Developments
11.10 Vabiotech
11.10.1 Vabiotech Corporation Information
11.10.2 Vabiotech Description and Business Overview
11.10.3 Vabiotech Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Vabiotech Oral Vaccine Products Offered
11.10.5 Vabiotech Related Developments
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Description and Business Overview
11.1.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Merck Oral Vaccine Products Offered
11.1.5 Merck Related Developments
11.12 EuBiologics
11.12.1 EuBiologics Corporation Information
11.12.2 EuBiologics Description and Business Overview
11.12.3 EuBiologics Sales, Revenue and Gross Margin (2015-2020)
11.12.4 EuBiologics Products Offered
11.12.5 EuBiologics Related Developments
11.13 Panacea Biotec Ltd
11.13.1 Panacea Biotec Ltd Corporation Information
11.13.2 Panacea Biotec Ltd Description and Business Overview
11.13.3 Panacea Biotec Ltd Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Panacea Biotec Ltd Products Offered
11.13.5 Panacea Biotec Ltd Related Developments
11.14 Bio-Med
11.14.1 Bio-Med Corporation Information
11.14.2 Bio-Med Description and Business Overview
11.14.3 Bio-Med Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Bio-Med Products Offered
11.14.5 Bio-Med Related Developments
11.15 Halfkin Bio-Pharmaceuticals
11.15.1 Halfkin Bio-Pharmaceuticals Corporation Information
11.15.2 Halfkin Bio-Pharmaceuticals Description and Business Overview
11.15.3 Halfkin Bio-Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Halfkin Bio-Pharmaceuticals Products Offered
11.15.5 Halfkin Bio-Pharmaceuticals Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Oral Vaccine Market Estimates and Projections by Region
12.1.1 Global Oral Vaccine Sales Forecast by Regions 2021-2026
12.1.2 Global Oral Vaccine Revenue Forecast by Regions 2021-2026
12.2 North America Oral Vaccine Market Size Forecast (2021-2026)
12.2.1 North America: Oral Vaccine Sales Forecast (2021-2026)
12.2.2 North America: Oral Vaccine Revenue Forecast (2021-2026)
12.2.3 North America: Oral Vaccine Market Size Forecast by Country (2021-2026)
12.3 Europe Oral Vaccine Market Size Forecast (2021-2026)
12.3.1 Europe: Oral Vaccine Sales Forecast (2021-2026)
12.3.2 Europe: Oral Vaccine Revenue Forecast (2021-2026)
12.3.3 Europe: Oral Vaccine Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Oral Vaccine Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Oral Vaccine Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Oral Vaccine Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Oral Vaccine Market Size Forecast by Region (2021-2026)
12.5 Latin America Oral Vaccine Market Size Forecast (2021-2026)
12.5.1 Latin America: Oral Vaccine Sales Forecast (2021-2026)
12.5.2 Latin America: Oral Vaccine Revenue Forecast (2021-2026)
12.5.3 Latin America: Oral Vaccine Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Oral Vaccine Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Oral Vaccine Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Oral Vaccine Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Oral Vaccine Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Oral Vaccine Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Oral Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Oral Vaccine Market Segments
Table 2. Ranking of Global Top Oral Vaccine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Oral Vaccine Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Rotavirus Vaccine
Table 5. Major Manufacturers of Cholera Vaccine
Table 6. Major Manufacturers of Oral Polio Vaccine
Table 7. Major Manufacturers of Others
Table 8. Global Oral Vaccine Market Size Growth Rate by Application 2020-2026 (K Units)
Table 9. Global Oral Vaccine Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 10. Global Oral Vaccine Sales by Regions 2015-2020 (K Units)
Table 11. Global Oral Vaccine Sales Market Share by Regions (2015-2020)
Table 12. Global Oral Vaccine Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Oral Vaccine Sales by Manufacturers (2015-2020) (K Units)
Table 14. Global Oral Vaccine Sales Share by Manufacturers (2015-2020)
Table 15. Global Oral Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Oral Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Vaccine as of 2019)
Table 17. Oral Vaccine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Oral Vaccine Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Oral Vaccine Price (2015-2020) (USD/Unit)
Table 20. Oral Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Oral Vaccine Product Type
Table 22. Date of International Manufacturers Enter into Oral Vaccine Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Oral Vaccine Sales by Type (2015-2020) (K Units)
Table 25. Global Oral Vaccine Sales Share by Type (2015-2020)
Table 26. Global Oral Vaccine Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Oral Vaccine Revenue Share by Type (2015-2020)
Table 28. Oral Vaccine Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 29. Global Oral Vaccine Sales by Application (2015-2020) (K Units)
Table 30. Global Oral Vaccine Sales Share by Application (2015-2020)
Table 31. North America Oral Vaccine Sales by Country (2015-2020) (K Units)
Table 32. North America Oral Vaccine Sales Market Share by Country (2015-2020)
Table 33. North America Oral Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 34. North America Oral Vaccine Revenue Market Share by Country (2015-2020)
Table 35. North America Oral Vaccine Sales by Type (2015-2020) (K Units)
Table 36. North America Oral Vaccine Sales Market Share by Type (2015-2020)
Table 37. North America Oral Vaccine Sales by Application (2015-2020) (K Units)
Table 38. North America Oral Vaccine Sales Market Share by Application (2015-2020)
Table 39. Europe Oral Vaccine Sales by Country (2015-2020) (K Units)
Table 40. Europe Oral Vaccine Sales Market Share by Country (2015-2020)
Table 41. Europe Oral Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe Oral Vaccine Revenue Market Share by Country (2015-2020)
Table 43. Europe Oral Vaccine Sales by Type (2015-2020) (K Units)
Table 44. Europe Oral Vaccine Sales Market Share by Type (2015-2020)
Table 45. Europe Oral Vaccine Sales by Application (2015-2020) (K Units)
Table 46. Europe Oral Vaccine Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific Oral Vaccine Sales by Region (2015-2020) (K Units)
Table 48. Asia Pacific Oral Vaccine Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific Oral Vaccine Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific Oral Vaccine Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific Oral Vaccine Sales by Type (2015-2020) (K Units)
Table 52. Asia Pacific Oral Vaccine Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific Oral Vaccine Sales by Application (2015-2020) (K Units)
Table 54. Asia Pacific Oral Vaccine Sales Market Share by Application (2015-2020)
Table 55. Latin America Oral Vaccine Sales by Country (2015-2020) (K Units)
Table 56. Latin America Oral Vaccine Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa Oral Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America Oral Vaccine Revenue Market Share by Country (2015-2020)
Table 59. Latin America Oral Vaccine Sales by Type (2015-2020) (K Units)
Table 60. Latin America Oral Vaccine Sales Market Share by Type (2015-2020)
Table 61. Latin America Oral Vaccine Sales by Application (2015-2020) (K Units)
Table 62. Latin America Oral Vaccine Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa Oral Vaccine Sales by Country (2015-2020) (K Units)
Table 64. Middle East and Africa Oral Vaccine Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa Oral Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa Oral Vaccine Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa Oral Vaccine Sales by Type (2015-2020) (K Units)
Table 68. Middle East and Africa Oral Vaccine Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa Oral Vaccine Sales by Application (2015-2020) (K Units)
Table 70. Middle East and Africa Oral Vaccine Sales Market Share by Application (2015-2020)
Table 71. Merck Corporation Information
Table 72. Merck Description and Major Businesses
Table 73. Merck Oral Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 74. Merck Product
Table 75. Merck Recent Development
Table 76. GSK Corporation Information
Table 77. GSK Description and Major Businesses
Table 78. GSK Oral Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 79. GSK Product
Table 80. GSK Recent Development
Table 81. Sanofi Corporation Information
Table 82. Sanofi Description and Major Businesses
Table 83. Sanofi Oral Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 84. Sanofi Product
Table 85. Sanofi Recent Development
Table 86. Lanzhou Institute Corporation Information
Table 87. Lanzhou Institute Description and Major Businesses
Table 88. Lanzhou Institute Oral Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 89. Lanzhou Institute Product
Table 90. Lanzhou Institute Recent Development
Table 91. Serum Institute Corporation Information
Table 92. Serum Institute Description and Major Businesses
Table 93. Serum Institute Oral Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 94. Serum Institute Product
Table 95. Serum Institute Recent Development
Table 96. Valneva Corporation Information
Table 97. Valneva Description and Major Businesses
Table 98. Valneva Oral Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 99. Valneva Product
Table 100. Valneva Recent Development
Table 101. Shanghai United Cell Corporation Information
Table 102. Shanghai United Cell Description and Major Businesses
Table 103. Shanghai United Cell Oral Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 104. Shanghai United Cell Product
Table 105. Shanghai United Cell Recent Development
Table 106. Bibcol Corporation Information
Table 107. Bibcol Description and Major Businesses
Table 108. Bibcol Oral Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 109. Bibcol Product
Table 110. Bibcol Recent Development
Table 111. PaxVax Corporation Information
Table 112. PaxVax Description and Major Businesses
Table 113. PaxVax Oral Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 114. PaxVax Product
Table 115. PaxVax Recent Development
Table 116. Vabiotech Corporation Information
Table 117. Vabiotech Description and Major Businesses
Table 118. Vabiotech Oral Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 119. Vabiotech Product
Table 120. Vabiotech Recent Development
Table 121. Tiantan Biological Corporation Information
Table 122. Tiantan Biological Description and Major Businesses
Table 123. Tiantan Biological Oral Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 124. Tiantan Biological Product
Table 125. Tiantan Biological Recent Development
Table 126. EuBiologics Corporation Information
Table 127. EuBiologics Description and Major Businesses
Table 128. EuBiologics Oral Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 129. EuBiologics Product
Table 130. EuBiologics Recent Development
Table 131. Panacea Biotec Ltd Corporation Information
Table 132. Panacea Biotec Ltd Description and Major Businesses
Table 133. Panacea Biotec Ltd Oral Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 134. Panacea Biotec Ltd Product
Table 135. Panacea Biotec Ltd Recent Development
Table 136. Bio-Med Corporation Information
Table 137. Bio-Med Description and Major Businesses
Table 138. Bio-Med Oral Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 139. Bio-Med Product
Table 140. Bio-Med Recent Development
Table 141. Halfkin Bio-Pharmaceuticals Corporation Information
Table 142. Halfkin Bio-Pharmaceuticals Description and Major Businesses
Table 143. Halfkin Bio-Pharmaceuticals Oral Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 144. Halfkin Bio-Pharmaceuticals Product
Table 145. Halfkin Bio-Pharmaceuticals Recent Development
Table 146. Global Oral Vaccine Sales Forecast by Regions (2021-2026) (K Units)
Table 147. Global Oral Vaccine Sales Market Share Forecast by Regions (2021-2026)
Table 148. Global Oral Vaccine Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 149. Global Oral Vaccine Revenue Market Share Forecast by Regions (2021-2026)
Table 150. North America: Oral Vaccine Sales Forecast by Country (2021-2026) (K Units)
Table 151. North America: Oral Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 152. Europe: Oral Vaccine Sales Forecast by Country (2021-2026) (K Units)
Table 153. Europe: Oral Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 154. Asia Pacific: Oral Vaccine Sales Forecast by Region (2021-2026) (K Units)
Table 155. Asia Pacific: Oral Vaccine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 156. Latin America: Oral Vaccine Sales Forecast by Country (2021-2026) (K Units)
Table 157. Latin America: Oral Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 158. Middle East and Africa: Oral Vaccine Sales Forecast by Country (2021-2026) (K Units)
Table 159. Middle East and Africa: Oral Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 160. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 161. Key Challenges
Table 162. Market Risks
Table 163. Main Points Interviewed from Key Oral Vaccine Players
Table 164. Oral Vaccine Customers List
Table 165. Oral Vaccine Distributors List
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
List of Figures
Figure 1. Oral Vaccine Product Picture
Figure 2. Global Oral Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Rotavirus Vaccine Product Picture
Figure 4. Cholera Vaccine Product Picture
Figure 5. Oral Polio Vaccine Product Picture
Figure 6. Others Product Picture
Figure 7. Global Oral Vaccine Sales Market Share by Application in 2020 & 2026
Figure 8. Public
Figure 9. Private
Figure 10. Oral Vaccine Report Years Considered
Figure 11. Global Oral Vaccine Market Size 2015-2026 (US$ Million)
Figure 12. Global Oral Vaccine Sales 2015-2026 (K Units)
Figure 13. Global Oral Vaccine Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Oral Vaccine Sales Market Share by Region (2015-2020)
Figure 15. Global Oral Vaccine Sales Market Share by Region in 2019
Figure 16. Global Oral Vaccine Revenue Market Share by Region (2015-2020)
Figure 17. Global Oral Vaccine Revenue Market Share by Region in 2019
Figure 18. Global Oral Vaccine Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Oral Vaccine Revenue in 2019
Figure 20. Oral Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Oral Vaccine Sales Market Share by Type (2015-2020)
Figure 22. Global Oral Vaccine Sales Market Share by Type in 2019
Figure 23. Global Oral Vaccine Revenue Market Share by Type (2015-2020)
Figure 24. Global Oral Vaccine Revenue Market Share by Type in 2019
Figure 25. Global Oral Vaccine Market Share by Price Range (2015-2020)
Figure 26. Global Oral Vaccine Sales Market Share by Application (2015-2020)
Figure 27. Global Oral Vaccine Sales Market Share by Application in 2019
Figure 28. Global Oral Vaccine Revenue Market Share by Application (2015-2020)
Figure 29. Global Oral Vaccine Revenue Market Share by Application in 2019
Figure 30. North America Oral Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 31. North America Oral Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Oral Vaccine Sales Market Share by Country in 2019
Figure 33. North America Oral Vaccine Revenue Market Share by Country in 2019
Figure 34. U.S. Oral Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 35. U.S. Oral Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Oral Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 37. Canada Oral Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Oral Vaccine Market Share by Type in 2019
Figure 39. North America Oral Vaccine Market Share by Application in 2019
Figure 40. Europe Oral Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 41. Europe Oral Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Oral Vaccine Sales Market Share by Country in 2019
Figure 43. Europe Oral Vaccine Revenue Market Share by Country in 2019
Figure 44. Germany Oral Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 45. Germany Oral Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Oral Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 47. France Oral Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Oral Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 49. U.K. Oral Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Oral Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 51. Italy Oral Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Oral Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 53. Russia Oral Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Oral Vaccine Market Share by Type in 2019
Figure 55. Europe Oral Vaccine Market Share by Application in 2019
Figure 56. Asia Pacific Oral Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 57. Asia Pacific Oral Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Oral Vaccine Sales Market Share by Region in 2019
Figure 59. Asia Pacific Oral Vaccine Revenue Market Share by Region in 2019
Figure 60. China Oral Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 61. China Oral Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Oral Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 63. Japan Oral Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Oral Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 65. South Korea Oral Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Oral Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 67. India Oral Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Oral Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 69. Australia Oral Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Oral Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 71. Taiwan Oral Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Oral Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 73. Indonesia Oral Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Oral Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 75. Thailand Oral Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Oral Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 77. Malaysia Oral Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Oral Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 79. Philippines Oral Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Oral Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 81. Vietnam Oral Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Oral Vaccine Market Share by Type in 2019
Figure 83. Asia Pacific Oral Vaccine Market Share by Application in 2019
Figure 84. Latin America Oral Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 85. Latin America Oral Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Oral Vaccine Sales Market Share by Country in 2019
Figure 87. Latin America Oral Vaccine Revenue Market Share by Country in 2019
Figure 88. Mexico Oral Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 89. Mexico Oral Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Oral Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 91. Brazil Oral Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Oral Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 93. Argentina Oral Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Oral Vaccine Market Share by Type in 2019
Figure 95. Latin America Oral Vaccine Market Share by Application in 2019
Figure 96. Middle East and Africa Oral Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 97. Middle East and Africa Oral Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Oral Vaccine Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Oral Vaccine Revenue Market Share by Country in 2019
Figure 100. Turkey Oral Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 101. Turkey Oral Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Oral Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 103. Saudi Arabia Oral Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Oral Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 105. U.A.E Oral Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Oral Vaccine Market Share by Type in 2019
Figure 107. Middle East and Africa Oral Vaccine Market Share by Application in 2019
Figure 108. North America Oral Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 109. North America Oral Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Europe Oral Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 111. Europe Oral Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Asia Pacific Oral Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 113. Asia Pacific Oral Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Latin America Oral Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. Latin America Oral Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Middle East and Africa Oral Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. Middle East and Africa Oral Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Porter's Five Forces Analysis
Figure 119. Channels of Distribution
Figure 120. Distributors Profiles
Figure 121. Bottom-up and Top-down Approaches for This Report
Figure 122. Data Triangulation
Figure 123. Key Executives Interviewed
ヒトロタウイルスワクチンの世界市場（～2026年） Rotavirus vaccine is used to protect against rotavirus infections which cause severe diarrhoea among young children. Symptoms of rotavirus infection include severe diarrhoea, vomiting, fever, and abdominal pain which can result in disease. Rotavirus vaccine is administered by mouth and requires two …- 全細胞コレラワクチンの世界市場（～2026年） Whole Cell Cholera Vaccine is used to prevent Cholera. The factors that fuel the growth of the global whole cell cholera vaccine (recombinant B-subunit) market are rising incidence of cholera among people in endemic regions along with a lack of sanitation and hygiene in certain countries. Market Ana…
- 腸チフスワクチンの世界市場（～2026年） Market Analysis and Insights: Global Typhoid Vaccine Market The global Typhoid Vaccine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Typhoid Vaccine Scope and Market Size Typhoid Vaccine market is segmented by Type, …
- 子宮頸がんワクチンの世界市場（～2026年） Market Analysis and Insights: Global Cervical Cancer Vaccine Market The global Cervical Cancer Vaccine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Cervical Cancer Vaccine Scope and Market Size Cervical Cancer Vacci…
- 結核ワクチン治療の世界市場（～2026年） Tuberculosis (TB) is an infectious disease which is caused by the bacteria called Mycobacterium tuberculosis (MTB). Tuberculosis mainly affects lungs, but can also affect other parts of the body. Typical signs of tuberculosis includes chronic or persistent cough and sputum production. When TB is at …